Osaic Holdings
COGT icon

Osaic Holdings’s Cogent Biosciences COGT Stock Holding History

Osaic Holdings’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.2K Sell
2,109
-6,378
-75% -$236K ﹤0.01% 4838
2025
Q4 		$301K Buy
8,487
+4,496
+113% +$126K ﹤0.01% 3808
2025
Q3 		$56.7K Sell
3,991
-559
-12% -$6.62K ﹤0.01% 5226
2025
Q2 		$32.5K Buy
4,550
+1,333
+41% +$7.39K ﹤0.01% 5351
2025
Q1 		$19.3K Buy
3,217
+688
+27% +$5.39K ﹤0.01% 5390
2024
Q4 		$19.7K Buy
2,529
+49
+2% +$488 ﹤0.01% 5353
2024
Q3 		$26.8K Buy
2,480
+694
+39% +$6.76K ﹤0.01% 5183
2024
Q2 		$15.1K Buy
+1,786
New +$13.5K ﹤0.01% 5535
2023
Q4 		– Sell
-17
Closed -$166 – 7330
2023
Q3 		$166 Hold
17
– – ﹤0.01% 7181
2023
Q2 		$201 Buy
17
+9
+113% +$103 ﹤0.01% 7207
2023
Q1 		$86 Buy
+8
New +$102 ﹤0.01% 7343
2020
Q2 		– Sell
-63
Closed – – 6140
2020
Q1 		$0 Buy
+63
New +$175 ﹤0.01% 6077

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Osaic Holdings's COGT Position: Q1 2026 in Review

Osaic Holdings reduced its Cogent Biosciences (COGT) stake by 75% in Q1 2026, selling an estimated $236K and leaving 2,109 shares worth $81.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4838.

Osaic Holdings first reported a position in COGT in Q1 2020 and has held it in 12 quarters since. The position peaked at $301K in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Osaic Holdings held 2,109 shares of Cogent Biosciences worth $81.2K as of Q1 2026.
  • Osaic Holdings sold 6,378 Cogent Biosciences shares in Q1 2026, an estimated $236K.
  • Cogent Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4838 holding.
  • Osaic Holdings first reported a position in Cogent Biosciences in Q1 2020 and has held it in 12 quarters since.
  • Osaic Holdings's Cogent Biosciences position peaked at $301K in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.